Humana Inc [HUM] stock is trading at $252.58, up 3.31%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The HUM shares have gain 5.77% over the last week, with a monthly amount glided 8.34%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Humana Inc [NYSE: HUM] stock has seen the most recent analyst activity on May 01, 2025, when Raymond James upgraded its rating to a Outperform but kept the price target unchanged to $315 for it. Previously, BofA Securities upgraded its rating to Neutral on November 06, 2024, and elevated its price target to $308. On October 11, 2024, KeyBanc Capital Markets initiated with a Sector Weight rating. Bernstein upgraded its rating to a Outperform but stick to its price target of $308 on October 08, 2024. TD Cowen downgraded its rating to a Hold and reduced its price target to $261 on October 07, 2024. Jefferies downgraded its rating to Hold for this stock on October 07, 2024, and downed its price target to $253. In a note dated October 03, 2024, Piper Sandler downgraded an Neutral rating on this stock and revised its target price from $392 to $274.
Humana Inc [HUM] stock has fluctuated between $212.45 and $406.46 over the past year. Currently, Wall Street analysts expect the stock to reach $274 within the next 12 months. Humana Inc [NYSE: HUM] shares were valued at $252.58 at the most recent close of the market. An investor can expect a potential return of 8.48% based on the average HUM price forecast.
Analyzing the HUM fundamentals
Humana Inc [NYSE:HUM] reported sales of 120.26B for the trailing twelve months, which represents a growth of 8.45%. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.1 and Total Capital is 0.1. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.75.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 245.31 points at the first support level, and at 238.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 256.37, and for the 2nd resistance point, it is at 260.15.
Ratios To Look Out For
For context, Humana Inc’s Current Ratio is 1.91. Considering the valuation of this stock, the price to sales ratio is 0.25, the price to book ratio is 1.72 and price to earnings (TTM) ratio is 17.86.
Transactions by insiders
Recent insider trading involved Rechtin James A., President & CEO, that happened on May 14 ’25 when 6530.0 shares were purchased. Former Chief Financial Officer, Diamond Susan M completed a deal on Apr 08 ’25 to buy 10959.0 shares. Meanwhile, Former Chief Administrative Of Huval Timothy S. bought 1247.0 shares on Feb 24 ’25.
